{
    "clinical_study": {
        "@rank": "132696", 
        "acronym": "Embryoscope", 
        "arm_group": [
            {
                "arm_group_label": "Study Arm", 
                "arm_group_type": "Experimental", 
                "description": "Subjects would receive recombinant Follicle Stimulating Hormone (rFSH) by S.C. injection 150 - 225 IU/day for 9 days. The embryos of subjects would be cultured by time-lapse imagery technique (embryoscope) and analysis would be done using  patients receive rFSH (Gonembryo viewer equipped with latest software."
            }, 
            {
                "arm_group_label": "Control Arm", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects would receive recombinant Follicle Stimulating Hormone (rFSH) by S.C. injection 150 - 225 IU/day for 9 days. The embryos of subjects would be cultured in conventional culture environment and analysis would be done using established subjective morphological criteria."
            }
        ], 
        "brief_summary": {
            "textblock": "1. Culture conditions of developing embryos are highly controlled in the Embryoscope and\n           are monitored by Time-lapse videography to produce 3D images at different stages.This\n           cannot be done under conventional culture conditions.\n\n        2. The 3D images thus produced,are analysed with the help of Embryoviewer, a part of the\n           Embryoscope,through latest software.\n\n        3. Embryoviewer also identifies embryos for transfer, freezing and to be discarded."
        }, 
        "brief_title": "Assessment of Implantation Potential of Embryos by Time-lapse Technology", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Embryo/Fetus Death", 
            "Blastocyst Disintegration", 
            "Aneuploidy", 
            "Complication of Implant", 
            "Chemical Pregnancy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aneuploidy", 
                "Embryo Loss", 
                "Fetal Death"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. There will be two arms of the study. The Study arm in which embryos of patients will be\n           cultured in the Embryoscope. The control arm in which the embryos  of patients will be\n           cultured under conventional conditions.\n\n        2. Embryos to be transferred will be identified by the Embryoviewer in the Study arm and\n           the ones in the control arm will be identified by established subjective morphological\n           criteria.\n\n        3. Embryos with definite implantation potential will be transferred in both arms.\n\n        4. Embryos not transferred will be frozen and/or discarded in both arms."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Women of age 21-39 yrs.\n\n          2. Basal FSH < 12mIU/ml\n\n          3. Anterior mullerian hormone(AMH) > 1.0 ng/ML\n\n          4. Antral follicle count (AFC) > 8\n\n          5. Body mass index (BMI) < 35 mt2/kg\n\n          6. Estradiol (E2) < 50PG/ML\n\n        Exclusion Criteria:\n\n          1. Women with one ovary.\n\n          2. Women in whom both ovaries are not seen on ultrasonography.\n\n          3. Women with too small uterine cavity.\n\n          4. Women with history of recurrent pregnancy loss\n\n          5. Women with systemic lupus erythematosus (SLE), Nephrotic syndrome, Meyer Rocky Tansky\n             Kustner Hammer(MRKH) syndrome,etc.\n\n          6. Human immunodeficiency virus (HIV) I and II positive women."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "39 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760278", 
            "org_study_id": "Time-lapse monitoring", 
            "secondary_id": "Study of embryo morphokinetics"
        }, 
        "intervention": {
            "arm_group_label": [
                "Study Arm", 
                "Control Arm"
            ], 
            "description": "There are two arms of the study. The Study arm and the Control arm. In each arm, subjects, after randomization, will be stimulated with rFSH 225IU/day.\nOn day 6, Cetrorelix 0.25mg/day to be added till the day of Ovitrell. Thereafter, ovum pick-up and embryo transfer to be done. Six weeks after transfer clinical pregnancy identified which will be the end-point of the study.", 
            "intervention_name": "recombinant Follicle Stimulating Hormone (rFSH)", 
            "intervention_type": "Drug", 
            "other_name": [
                "Gonal-F", 
                "Progesterone vaginal", 
                "Ovitrell 250mcg", 
                "Cetrorelix 0.25 mg"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Hormones", 
                "Progesterone", 
                "Follicle Stimulating Hormone", 
                "Cetrorelix"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Time-lapse monitoring of embryos.", 
            "Embryoscope", 
            "IVF-ET/ICSI", 
            "Cetrorelix", 
            "Gonal-F"
        ], 
        "lastchanged_date": "January 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mumbai", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "400050"
                }, 
                "name": "Lilavati Hospital and Research Center, IVF department"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of Implantation Potential of Embryos Cultured by Time-lapse Technology (Embryoscope) Before Transfer in In-vitro Fertilization (IVF) / Intracytoplasmic Sperm Injection (ICSI) Cycles: A Randomized Control Study.", 
        "other_outcome": {
            "description": "Mature oocyte identified by presence of polar body, fluffy granulosa cells surrounded by corona radiata.", 
            "measure": "No. of mature M2 oocytes obtained", 
            "safety_issue": "No", 
            "time_frame": "2 weeks"
        }, 
        "overall_official": [
            {
                "affiliation": "Bloom IVF and Fertility Centre", 
                "last_name": "Hrishikesh D Pai, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Bloom IVF and Fertility Centre", 
                "last_name": "Manchi R Bharucha, Ph.D.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "4-cell embryos on day 2 of fertilization in both,Study arm and Control arm.\n8-cell embryos on day 3 of fertilization in both Study arm and Control arm.\nBlastocyst embryos on day 5 or day 6 of fertilization in both Study arm and Control arm.", 
            "measure": "No.of top quality embryos produced in both the arms, study arm and control arm.", 
            "safety_issue": "No", 
            "time_frame": "2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760278"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "18765009", 
            "citation": "Lemmen JG, Agerholm I, Ziebe S. Kinetic markers of human embryo quality using time-lapse recordings of IVF/ICSI-fertilized oocytes. Reprod Biomed Online. 2008 Sep;17(3):385-91."
        }, 
        "secondary_outcome": {
            "description": "Clinical pregnancy will be identified by presence of gestational sac(s) and fetal heart-beat by transvaginal ultrasonography in sixth week after embryo transfer.", 
            "measure": "Clinical pregnancy", 
            "safety_issue": "Yes", 
            "time_frame": "6 weeks after embryo transfer (ET)"
        }, 
        "source": "Bloom IVF and Fertility Centre", 
        "sponsors": {
            "collaborator": {
                "agency": "Padmashree Dr. D. Y. Patil Medical College", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Bloom IVF and Fertility Centre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}